Androgen receptor expression and breast cancer survival in postmenopausal women (Q34164902)

31 July 2017

title

Androgen receptor expression and breast cancer survival in postmenopausal women (English)

1 reference

31 July 2017

1 reference

Graham A Colditz

9

0 references

Susan E. Hankinson

series ordinal

8

object named as

Susan E Hankinson

1 reference

31 July 2017

10

Rulla M Tamimi

1 reference

31 July 2017

7

Jonathan D Marotti

1 reference

31 July 2017

5

Stuart J Schnitt

1 reference

31 July 2017

3

Michelle D Holmes

1 reference

31 July 2017

2

Shaheenah Dawood

1 reference

31 July 2017

4

Laura C Collins

1 reference

31 July 2017

Rong Hu

1

1 reference

31 July 2017

Kimberley Cole

series ordinal

6

1 reference

31 July 2017

language of work or name

English

0 references

publication date

15 February 2011

1 reference

31 July 2017

published in

Clinical Cancer Research

1 reference

31 July 2017

volume

17

1 reference

31 July 2017

issue

7

1 reference

31 July 2017

page(s)

1867-1874

1 reference

Androgen receptor inhibits estrogen receptor-alpha activity and is prognostic in breast cancer

31 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Breast cancer subtypes based on ER/PR and Her2 expression: comparison of clinicopathologic features and survival

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Androgen-induced human breast cancer cell proliferation is mediated by discrete mechanisms in estrogen receptor-alpha-positive and -negative breast cancer cells

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Androgen receptor as a target for the treatment of hormone receptor-negative breast cancer: an unchartered territory

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Prognostic markers in triple-negative breast cancer

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

An estrogen receptor-negative breast cancer subset characterized by a hormonally regulated transcriptional program and response to androgen

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Identification of molecular apocrine breast tumours by microarray analysis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

The clinical significance of androgen receptors in breast cancer and their relation to histological and cell biological parameters

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Androgen receptors, serum androgen levels and survival of breast cancer patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Oestrogen and androgen receptors in breast cancer and response to endocrine therapy

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Expression and clinical significance of androgen receptor in triple negative breast cancer.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Expression of androgen receptors in primary breast cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Androgen receptor levels and association with PIK3CA mutations and prognosis in breast cancer.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Androgen receptor expression in breast cancer: relationship with clinicopathological factors and biomarkers

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Prognostic relevance of androgen receptor detection in operable breast cancer

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Androgen Receptor Expression in Estrogen Receptor-Negative Breast Cancer Immunohistochemical, Clinical, and Prognostic Associations

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Test of the National Death Index and Equifax Nationwide Death Search.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Smoking and survival after breast cancer diagnosis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3076683

Androgen receptor expression is a significant prognostic factor in estrogen receptor positive breast cancers

28 October 2018

1 reference

12 December 2020

Association between steroid hormone receptor status and disease-free interval in breast cancer

1 reference

12 December 2020

Test of the National Death Index

1 reference

12 December 2020

Androgen receptors in breast cancer

1 reference

12 December 2020

Androgen receptors in operable breast cancer: relation to other steroid hormone receptors, correlations to prognostic factors and predictive value for effect of adjuvant tamoxifen treatment

1 reference

12 December 2020

Using the National Death Index to obtain underlying cause of death codes

1 reference

12 December 2020

Evaluation of the prognostic significance of androgen receptor expression in metastatic breast cancer

1 reference

12 December 2020

10.1158/1078-0432.CCR-10-2021

Identifiers

DOI

1 reference

31 July 2017

1 reference

31 July 2017

1 reference